BAMCO Inc’s Bristol-Myers Squibb BMY Stock Holding History

BAMCO Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-40,000	Closed	-$2.84M	–	379
2022 Q3	$2.84M	Sell	40,000 -21,000	-34%	-$1.52M	0.01%	299
2022 Q2	$4.7M	Buy	+61,000	New	+$4.65M	0.02%	286
2016 Q4	–	Sell	-47,479	Closed	-$2.56M	–	323
2016 Q3	$2.56M	Sell	47,479 -67,462	-59%	-$4.33M	0.01%	235
2016 Q2	$8.45M	Buy	114,941 +2,093	+2%	+$148K	0.04%	193
2016 Q1	$7.21M	Buy	+112,848	New	+$7.12M	0.04%	204

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BAMCO Inc's BMY Position: Q4 2022 in Review

BAMCO Inc sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 40,000 shares — an estimated $2.84M sold.

BAMCO Inc first reported a position in BMY in Q1 2016 and held it in 5 quarters. The position peaked at $8.45M in Q2 2016. 2,602 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

BAMCO Inc reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
BAMCO Inc sold 40,000 Bristol-Myers Squibb shares in Q4 2022, an estimated $2.84M.
BAMCO Inc first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 5 quarters.
BAMCO Inc's Bristol-Myers Squibb position peaked at $8.45M in Q2 2016.
2,602 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on BAMCO Inc's 13F filing for Q4 2022, filed 14 Feb 2023.